SCHEMBL13310487

SCHEMBL13310487

COc1ccc(-c2ccc3cc(C(=O)NO)ccc3c2)cc1C1C2CC3CC(C2)CC1C3

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RARA P10276 3/20 0.49
RARB P10826 3/20 0.49
RARG P13631 3/20 0.49
MEN1 O00255 1/20 0.49
NR1I2 O75469 1/20 0.49
LMNA P02545 1/20 0.49
PGR P06401 1/20 0.49
HSPD1 P10809 1/20 0.49
GOT1 P17174 1/20 0.49
GLRA1 P23415 1/20 0.49
BLM P54132 1/20 0.49
HSPE1 P61604 1/20 0.49
KMT2A Q03164 1/20 0.49
TDP1 Q9NUW8 1/20 0.49
SCN9A Q15858 2/20 0.44
PLAU P00749 1/20 0.44
HDAC6 Q9UBN7 5/20 0.43
HDAC8 Q9BY41 4/20 0.43
HDAC1 Q13547 3/20 0.43
PKM P14618 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13067866 0.86 PDE4A (0.51) RARARARBRARGMEN1NR1I2
SCHEMBL13310489 0.84 RARB (0.46) RARARARBRARGMEN1KMT2A
SCHEMBL641032 0.80 HTR2C (0.43) RARARARBRARGMEN1NR1I2
SCHEMBL13294272 0.79 RARB (0.78) RARARARBRARGMEN1NR1I2
SCHEMBL14393098 0.78 RARB (0.60) RARARARBRARGMEN1NR1I2
SCHEMBL13310493 0.77 HDAC2 (0.64) HDAC6HDAC8HDAC1HDAC11
SCHEMBL5315345 0.74 HDAC11 (0.50) RARBKMT2AHDAC6HDAC8HDAC1
SCHEMBL5315348 0.74 HDAC11 (0.50) RARBKMT2AHDAC6HDAC8HDAC1
SCHEMBL5616739 0.72 RARB (0.63) RARARARBRARGMEN1NR1I2
SCHEMBL13937353 0.72 RARB (0.57) RARARARBRARGMEN1NR1I2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7728039-B2 Biphenyl and Naphthyl-Phenyl Hydroxamic Acid Derivatives SIGMA-TAU INDUSTRIE FARMACEUTICHE RIUNITE S.P.A. (IT) 2010-06-01 US disclosed
US-20080319082-A1 Biphenyl and Naphthyl-Phenyl Hydroxamic Acid Derivatives SIGMA-TAU INDUSTRIE FARMACEUTICHE RIUNITE S.P.A. (IT) 2008-12-25 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080319082-A1 Biphenyl and Naphthyl-Phenyl Hydroxamic Acid Derivatives VHL, ARNT, AHR RARA 290/4885RARB 136/4885RARG 246/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.